Introduction of human papillomavirus vaccination in Nordic countriesArchived
The paper provides and interesting review of the introduction of HPV vaccines in the Nordic countries.
Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Vaccine. 2011 Dec 6. [Epub ahead of print]
Although culturally and historically close, these countries have a different HPV epidemiology, and important variations were observed in the way the vaccination was introduced across Nordic countries.
In contrast to other countries Norway did not include a catch-up program, whereas Denmark recently decided to include women up to the age of 26 years in the vaccination program. Sweden and Iceland at first decided to use the bivalent vaccine, whereas the other countries chose the quadrivalent vaccine.
The vaccine is delivered in school-based settings in Norway, Sweden and Iceland, whereas a mixed setting is used in Greenland and a primary setting in Denmark. Following the advice of the ECDC and the WHO, Norway, Sweden and Iceland have set up regular vaccination registers, whereas Greenland has not done so, and Denmark is in the process of establishing a comprehensive register.
Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
1 Apr 2019 - ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Conclusions of the twentieth IHR Emergency Committee do not change the ECDC risk assessment for Europe concerning polio
11 Mar 2019 - Statement of the twentieth IHR Emergency Committee Regarding the International Spread of Poliovirus, 1 March 2019
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
1 Mar 2019 - On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).